Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.
Corneal Dystrophy Research Institute, Severance Biomedical Science Institute, and Brain Korea 21 Project for Medical Science, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.
Korean J Ophthalmol. 2020 Feb;34(1):76-84. doi: 10.3341/kjo.2019.0109.
To investigate clinical outcomes of small incision lenticule extraction (SMILE) including vector parameters and corneal aberrations in myopic patients.
This retrospective, observational case series included 57 eyes (29 patients) that received treatment for myopia using SMILE. Visual acuity measurement, manifest refraction, slit-lamp examination, autokeratometry, corneal topography, and evaluation of corneal wavefront aberration were performed preoperatively and at 1 and 3 months after surgery. We analyzed the safety, efficacy, vector parameters, and corneal aberrations at 3 months after surgery.
Preoperatively, mean manifest refraction spherical equivalent refraction was -4.94 ± 1.94 D (range, -8.25 to 0 diopters [D]), and the cylinder was -1.14 ± 0.82 D (range, -3 to 0 D). Mean manifest refraction spherical equivalent improved to -0.10 ± 0.23 D at 3 months postoperatively, when uncorrected distance visual acuity was 20 / 20 or better in 55 (96%) eyes. The linear regression model of target induced astigmatism vector versus surgically induced astigmatism vector exhibited slopes and coefficients (²) of 0.9618 and 0.9748, respectively (y = 0.9618x + 0.0006, ² = 0.9748). While total corneal root mean square higher order aberrations, coma and trefoil showed statistically significant increase, spherical aberration did not show statistically significant change after SMILE.
SMILE has proven to be effective and safe for correcting myopia and astigmatism. We showed that SMILE did not induce spherical aberrations. A small increase in postoperative corneal higher order aberration may be associated with increase in coma and trefoil.
研究小切口微透镜提取术(SMILE)治疗近视的临床效果,包括向量参数和角膜像差。
本回顾性观察性病例系列研究纳入了 57 只眼(29 例),这些眼均因近视接受了 SMILE 治疗。术前及术后 1 个月和 3 个月时,进行视力测量、主觉验光、裂隙灯检查、角膜自动验光仪检查、角膜地形图检查和角膜波前像差评估。我们分析了术后 3 个月时的安全性、有效性、向量参数和角膜像差。
术前,平均等效球镜屈光度为-4.94±1.94 D(范围:-8.25 至 0 屈光度[D]),柱镜为-1.14±0.82 D(范围:-3 至 0 D)。术后 3 个月时,平均等效球镜屈光度改善至-0.10±0.23 D,此时 55 只眼(96%)的未矫正远视力达到 20/20 或更好。目标诱导散光向量与手术诱导散光向量的线性回归模型显示斜率和系数(²)分别为 0.9618 和 0.9748(y = 0.9618x + 0.0006,² = 0.9748)。虽然总角膜均方根高阶像差、彗差和三叶草像差均有统计学显著增加,但 SMILE 术后球差无统计学显著变化。
SMILE 已被证明可有效、安全地矫正近视和散光。我们发现 SMILE 不会引起球差。术后角膜高阶像差的小幅度增加可能与彗差和三叶草像差的增加有关。